Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues	$ 15,995,000	$ 9,297,000
Cost of Revenues	4,374,000	2,613,000
Gross Profit	11,621,000	6,684,000
Operating Expenses
Research and development	14,121,000	6,523,000
Sales and marketing	8,261,000	5,331,000
General and administrative	41,352,000	15,261,000
Acquisition-related costs	1,248,000	1,057,000
Impairment of goodwill	14,789,000	0
Amortization of intangibles	4,467,000	2,306,000
Total Operating Expenses	84,238,000	30,478,000
Loss from Operations	(72,617,000)	(23,794,000)
Other Income (Expense)
Interest expense, net	1,183,000	(2,426,000)
Loss on exchange of debt for equity	(30,000)	(210,000)
Benefit (provision) for valuation allowance on related party loan - held for sale	7,345,000	(2,370,000)
Other income (expense)	(173,000)	(470,000)
Gain on related party loan - held for sale	49,817,000	0
Unrealized loss on equity securities	(57,067,000)	0
Total Other Income (Expense)	1,075,000	(5,476,000)
Net Loss, before tax	(71,542,000)	(29,270,000)
Income tax benefit	1,412,000	56,000
Net Loss	(70,130,000)	(29,214,000)
Net Income (Expense) Attributable to Non-controlling Interest	(975,000)	15,000
Net Loss Attributable to Stockholders of Inpixon	(69,155,000)	(29,229,000)
Accretion of Series 7 preferred stock	(8,161,000)	0
Net Income (Loss) Available to Common Stockholders, Basic	(77,316,000)	(29,229,000)
Net Loss Attributable to Common Stockholders, Diluted	$ (77,316,000)	$ (29,229,000)
Net Loss Per Share - Basic (in usd per share)	$ (0.72)	$ (1.01)
Net Loss Per Share - Diluted (in usd per share)	$ (0.72)	$ (1.01)
Weighted Average Shares Outstanding
Basic (in shares)	107,981,441	28,800,493
Diluted (in shares)	107,981,441	28,800,493